📋 Dennis Phillip Andrew (Chief Medical Officer) plans to sell 4K shares of NovaBridge Biosciences (at $2.79 each, total $10K) Filed: Mar 18, 2026 | ID: 000121
Director DOUMET ANTOINE M 🟡 adjusted position in 0 shares (1 derivative) of UNITED STATES LIME & MINERALS INC (USLM) at $10.71 Transaction Date: Mar 17, 2026 | Filing ID: 000007
Doyle Mittie 🟡 adjusted position in 25.5K shares (2 derivative) of Avalo Therapeutics, Inc. (AVTX) at $16.15 ($1.0M) Transaction Date: Mar 16, 2026 | Filing ID: 000004